首页> 外国专利> Angiotensin iv and analogs as regulators of fibrinolysis

Angiotensin iv and analogs as regulators of fibrinolysis

机译:血管紧张素IV和类似物作为纤维蛋白溶解的调节剂

摘要

Angiotensin IV (VAL-TYR-ILE-HIS-PRO-PHE), a degradation product of angiotensin II previously thought to be inactive, interacts directly with endothelial cells to induce expression of PAI-1 and thereby to inhibit clot lysis attributable to endogenous t-PA. Moreover, angiotensin IV does not effect substantial physiological changes (vasoconstriction, increased blood pressure, etc.) characteristic of angiotensin II. Fibrinolysis is promoted by reducing the amount or the effect of angiotensin IV. Fibrinolysis is inhibited by providing enhanced angiotensin IV. Methods of screening candidates for antagonizing angiotensin IV are also disclosed.
机译:血管紧张素IV(VAL-TYR-ILE-HIS-PRO-PHE)是血管紧张素II的降解产物,以前被认为是无活性的,它直接与内皮细胞相互作用,诱导PAI-1表达,从而抑制归因于内源性t的凝块溶解-PA。而且,血管紧张素IV不影响血管紧张素II的实质生理变化(血管收缩,血压升高等)。通过减少血管紧张素IV的量或作用来促进纤维蛋白溶解。通过提供增强的血管紧张素IV抑制纤维蛋白溶解。还公开了筛选用于拮抗血管紧张素IV的候选物的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号